Michael Tees

1.1k total citations
49 papers, 678 citations indexed

About

Michael Tees is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Michael Tees has authored 49 papers receiving a total of 678 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 19 papers in Pathology and Forensic Medicine and 15 papers in Genetics. Recurrent topics in Michael Tees's work include CAR-T cell therapy research (30 papers), Lymphoma Diagnosis and Treatment (17 papers) and Chronic Lymphocytic Leukemia Research (15 papers). Michael Tees is often cited by papers focused on CAR-T cell therapy research (30 papers), Lymphoma Diagnosis and Treatment (17 papers) and Chronic Lymphocytic Leukemia Research (15 papers). Michael Tees collaborates with scholars based in United States, United Kingdom and Spain. Michael Tees's co-authors include Lydia Bazzano, Angela M. Thompson, Catherine Nguyen, Donna M. Winham, Ian W. Flinn, Frederick L. Locke, Sattva S. Neelapu, David B. Miklos, Xu Xiong and Gabriella Pridjian and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

Michael Tees

45 papers receiving 653 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Tees United States 13 266 157 155 132 112 49 678
Carole Brosseau France 16 92 0.3× 256 1.6× 68 0.4× 27 0.2× 55 0.5× 28 723
Neal Smith United States 13 34 0.1× 281 1.8× 37 0.2× 127 1.0× 51 0.5× 16 734
Masafumi Seki Japan 12 49 0.2× 159 1.0× 36 0.2× 35 0.3× 44 0.4× 50 392
Seyed Mehdi Hashemi Iran 17 61 0.2× 281 1.8× 42 0.3× 20 0.2× 13 0.1× 79 765
Satoshi Inaba Japan 8 33 0.1× 45 0.3× 50 0.3× 88 0.7× 12 0.1× 23 305
Yiwei Ling Japan 13 130 0.5× 234 1.5× 59 0.4× 21 0.2× 10 0.1× 47 545
Kıymet Baz Türkiye 12 59 0.2× 84 0.5× 45 0.3× 57 0.4× 5 0.0× 27 688
E. O. Ukaejiofo Nigeria 6 41 0.2× 102 0.6× 20 0.1× 62 0.5× 40 0.4× 9 435
Nitya Jain United States 10 128 0.5× 209 1.3× 16 0.1× 98 0.7× 9 0.1× 17 708

Countries citing papers authored by Michael Tees

Since Specialization
Citations

This map shows the geographic impact of Michael Tees's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Tees with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Tees more than expected).

Fields of papers citing papers by Michael Tees

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Tees. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Tees. The network helps show where Michael Tees may publish in the future.

Co-authorship network of co-authors of Michael Tees

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Tees. A scholar is included among the top collaborators of Michael Tees based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Tees. Michael Tees is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martin, Casey, Betsy Blunk, Sarah T. Garber, et al.. (2025). Remote Patient Monitoring for 15 Vs. 30 Days in Outpatient Chimeric Antigen Receptor T-Cell Therapy (CAR-T) across a Large Health System. Transplantation and Cellular Therapy. 31(2). S223–S224.
2.
Locke, Frederick L., Javier Muñoz, Michael Tees, et al.. (2025). Allogeneic Chimeric Antigen Receptor T-Cell Products Cemacabtagene Ansegedleucel/ALLO-501 in Relapsed/Refractory Large B-Cell Lymphoma: Phase I Experience From the ALPHA2/ALPHA Clinical Studies. Journal of Clinical Oncology. 43(14). 1695–1705. 11 indexed citations
3.
Majhail, Navneet S., Minoo Battiwalla, Aravind Ramakrishnan, et al.. (2025). Outpatient Administration of Chimeric Antigen Receptor T-Cell Therapy Using Remote Patient Monitoring. JCO Oncology Practice. 21(11). 1601–1608. 1 indexed citations
4.
Martin, Casey, Betsy Blunk, Aravind Ramakrishnan, et al.. (2024). Comparison of 15- Vs. 30-Day Remote Patient Monitoring for Outpatient Chimeric Antigen Receptor T-Cell Therapy (CAR-T) across a Large Health System. Blood. 144(Supplement 1). 2300–2300. 1 indexed citations
5.
Woyach, Jennifer A., et al.. (2024). Abstract CT156: A Phase I study evaluating AC676, an innovative BTK chimeric degrader, in patients with relapsed and refractory B-cell malignancies. Cancer Research. 84(7_Supplement). CT156–CT156. 2 indexed citations
6.
Patel, Manish R., Michael Tees, Farrukh T. Awan, et al.. (2024). Abstract PO-009: AC676 a BTK Chimeric Degrader: Phase 1 study in patients with B-cell Malignancies. Blood Cancer Discovery. 5(3_Supplement). PO–9. 3 indexed citations
7.
Battiwalla, Minoo, Michael Tees, Ian W. Flinn, et al.. (2024). Access barriers to anti-CD19+ CART therapy for NHL across a community transplant and cellular therapy network. Blood Advances. 9(2). 429–435. 4 indexed citations
8.
Landsburg, Daniel J., Richard T. Maziarz, Amy Moskop, et al.. (2024). Efficacy and Safety of Tisagenlecleucel in Patients with Relapsed/Refractory Follicular Lymphoma: A Real-World Analysis from the Center for Blood and Marrow Transplant Research (CIBMTR) Registry. Blood. 144(Supplement 1). 4398–4398. 1 indexed citations
9.
Patel, Manish, Michael Tees, Nadia Khan, et al.. (2024). IBCL-147 AC676, an Orally Bioavailable BTK Chimeric Degrader in Patients With B-cell Malignancies. Clinical Lymphoma Myeloma & Leukemia. 24. S494–S494. 3 indexed citations
10.
Ghobadi, Armin, Caron A. Jacobson, Joseph P. McGuirk, et al.. (2024). Phase 2 open label, multicenter study evaluating CRG-022, a CD22-directed autologous CAR T-cell therapy, in patients (pts) with relapsed/refractory (R/R) large B-cell lymphoma (LBCL) after CD19-directed CAR T-cell therapy.. Journal of Clinical Oncology. 42(16_suppl). TPS7085–TPS7085. 1 indexed citations
11.
O’Connor, Kevin C., Richard J. Nowak, Minh Pham, et al.. (2023). Remission of severe myasthenia gravis after autologous stem cell transplantation. Annals of Clinical and Translational Neurology. 10(11). 2105–2113. 1 indexed citations
12.
Westin, Jason R., Caron A. Jacobson, Julio C. Chávez, et al.. (2023). PB2319: ZUMA-23: A GLOBAL, PHASE 3, RANDOMIZED CONTROLLED STUDY OF AXICABTAGENE CILOLEUCEL VERSUS STANDARD OF CARE AS FIRST-LINE THERAPY IN PATIENTS WITH HIGH-RISK LARGE B-CELL LYMPHOMA. HemaSphere. 7(S3). e3278692–e3278692. 1 indexed citations
13.
Battiwalla, Minoo, Michael Tees, Ian W. Flinn, et al.. (2023). Access Barriers for Anti-CD19+ Chimeric Antigen Receptor T (CAR-T) Cell Therapy for Non-Hodgkin Lymphoma (NHL) across a Large Community Transplant and Cellular Therapy Network. Transplantation and Cellular Therapy. 29(2). S55–S55. 2 indexed citations
14.
Eradat, Herbert, Jennifer A. Woyach, Ian W. Flinn, et al.. (2023). Updated follow‐up of BELLWAVE‐001: an open‐label, single‐arm, phase 1/2 study of the efficacy and safety of nemtabrutinib for the treatment of B‐cell malignancies. Hematological Oncology. 41(S2). 565–567. 1 indexed citations
15.
16.
Tees, Michael & Lubomir Sokol. (2014). Novel Immunotherapies for B-Cell Lymphomas and Leukemias. American Journal of Therapeutics. 23(5). e1157–e1181. 2 indexed citations
17.
Tees, Michael & Lubomir Sokol. (2014). Novel Pharmacotherapies for B-Cell Lymphomas and Leukemias. American Journal of Therapeutics. 23(2). e498–e520. 1 indexed citations
18.
Klimek, Virginia M., Michael Tees, Sean M. Devlin, et al.. (2012). Efficacy of hypomethylating agents in therapy-related myelodysplastic syndromes. Leukemia Research. 36(9). 1093–1097. 25 indexed citations
19.
Bazzano, Lydia, Angela M. Thompson, Michael Tees, Catherine Nguyen, & Donna M. Winham. (2009). Non-soy legume consumption lowers cholesterol levels: A meta-analysis of randomized controlled trials. Nutrition Metabolism and Cardiovascular Diseases. 21(2). 94–103. 223 indexed citations
20.
Bazzano, Lydia, et al.. (2008). Abstract 3272: Effect of Non-Soy Legume Consumption on Cholesterol Levels: A Meta-Analysis of Randomized Controlled Trials. Circulation. 118. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carole Brosseau Breakdown of academic impact, for papers by Neal Smith Breakdown of academic impact, for papers by Masafumi Seki Breakdown of academic impact, for papers by Seyed Mehdi Hashemi Breakdown of academic impact, for papers by Satoshi Inaba Breakdown of academic impact, for papers by Yiwei Ling Breakdown of academic impact, for papers by Kıymet Baz Breakdown of academic impact, for papers by E. O. Ukaejiofo Breakdown of academic impact, for papers by Nitya Jain
Rankless by CCL
2026